The Chatterjee Group

The Chatterjee Group (TCG) is a global investment conglomerate with a significant presence in the life sciences sector, primarily through its subsidiary TCG Lifesciences. Founded by Dr. Purnendu Chatterjee, the group provides comprehensive drug discovery and development services, including medicinal chemistry, ADME, and clinical research. TCG Lifesciences operates as a leading Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO), supporting global pharmaceutical and biotech companies. The group also invests in laboratory informatics through LabVantage and advanced scientific research via TCG Crest. With operations spanning India, the United States, and Europe, TCG facilitates the transition of drug candidates from lead optimization to clinical trials. Their expertise covers diverse therapeutic areas such as oncology, inflammation, and infectious diseases.